Cited by 117Tissue Engineering and Regenerative Medicine3D Printing in Biomedical ResearchMesenchymal stem cell research

Cryo-chemical decellularization of the whole liver for mesenchymal stem cells-based functional hepatic tissue engineering

Open access
Jiang, Wei-Cheng, Cheng, Yu-Hao, Yen, Meng-Hua, Chang, Yin, Yang, Vincent W., Lee, Oscar K.·2014·Biomaterials

Abstract

Liver transplantation is the ultimate treatment for severe hepatic failure to date. However, the limited supply of donor organs has severely hampered this treatment. So far, great potentials of using mesenchymal stem cells (MSCs) to replenish the hepatic cell population have been shown; nevertheless, there still is a lack of an optimal three-dimensional scaffold for generation of well-transplantable hepatic tissues. In this study, we utilized a cryo-chemical decellularization method which combines physical and chemical approach to generate acellular liver scaffolds (ALS) from the whole liver. The produced ALS provides a biomimetic three-dimensional environment to support hepatic differentiation of MSCs, evidenced by expression of hepatic-associated genes and marker protein, glycogen storage, albumin secretion, and urea production. It is also found that hepatic differentiation of MSCs within the ALS is much more efficient than two-dimensional culture in vitro. Importantly, the hepatic-like tissues (HLT) generated by repopulating ALS with MSCs are able to act as functional grafts and rescue lethal hepatic failure after transplantation in vivo. In summary, the cryo-chemical method used in this study is suitable for decellularization of liver and create acellular scaffolds that can support hepatic differentiation of MSCs and be used to fabricate functional tissue-engineered liver constructs.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.biomaterials.2014.01.024

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Jiang et al. found that the three-dimensional environment of decellularized liver supported hepatic differentiation of MSCs, as evidenced by higher expression levels of hepatic-specific genes and marker proteins, increased glycogen storage, albumin secretion, and urea production compared to cells differentiated in 2D cultures.

    “The three-dimensional environment of the decellularized liver supported the hepatic differentiation of MSCs, as evidenced by higher expression levels of hepatic-specific genes and marker proteins, increased glycogen storage, albumin secretion, and urea production compared to cells differentiated in 2D cultures.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 33

  1. [1]Brown RS Jr Live donors in liver transplantation. Gastroenterology 2008 134 1802 13 18471556 PMC2654217
  2. [2]Dalgetty DM Medine CN Iredale JP Hay DC Progress and future challenges in stem cell-derived liver technologies. Am J Physiol Gastrointest Liver Physiol 2009 297 241 8 19520740
  3. [3]Lee KD Kuo TK Whang-Peng J Chung YF Lin CT Chou SH In vitro hepatic differentiation of human mesenchymal stem cells. Hepatology 2004 40 1275 84 15562440
  4. [4]Dai LJ Li HY Guan LX Ritchie G Zhou JX The therapeutic potential of bone marrow-derived mesenchymal stem cells on hepatic cirrhosis. Stem Cell Res 2009 2 16 25 19383405
  5. [5]Kuo TK Hung SP Chuang CH Chen CT Shih YR Fang SC Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells. Gastroenterology 2008 134 2111 21 18455168 PMC3086672
  6. [6]Bhatia SK Tissue engineering for clinical applications. Biotechnol J 2010 5 1309 23 21154670
  7. [7]Chan BP Leong KW Scaffolding in tissue engineering: general approaches and tissue-specific considerations. Eur Spine J 2008 17 467 79 19005702 PMC2587658
  8. [8]Ranucci CS Moghe PV Polymer substrate topography actively regulates the multicellular organization and liver-specific functions of cultured hepatocytes. Tissue Eng 1999 5 407 20 10586097
  9. [9]Kim SS Utsunomiya H Koski JA Wu BM Cima MJ Sohn J Survival and function of hepatocytes on a novel three-dimensional synthetic biodegradable polymer scaffold with an intrinsic network of channels. Ann Surg 1998 228 8 13 9671060 PMC1191421
  10. [10]Underhill GH Chen AA Albrecht DR Bhatia SN Assessment of hepatocellular function within PEG hydrogels. Biomaterials 2007 28 256 70 16979755
  11. [11]Sugimoto S Harada K Shiotani T Ikeda S Katsura N Ikai I Hepatic organoid formation in collagen sponge of cells isolated from human liver tissues. Tissue Eng 2005 11 626 33 15869439
  12. [12]Takimoto Y Dixit V Arthur M Gitnick G De novo liver tissue formation in rats using a novel collagen-polypropylene scaffold. Cell Transplant 2003 12 413e 21 12911129
  13. [13]Seo SJ Choi YJ Akaike T Higuchi A Cho CS Alginate/galactosylated chitosan/ heparin scaffold as a new synthetic extracellular matrix for hepatocytes. Tissue Eng 2006 12 33 44 16499440
  14. [14]Cheng N Wauthier E Reid LM Mature human hepatocytes from ex vivo differentiation of alginate-encapsulated hepatoblasts. Tissue Eng Part A 2008 14 1 7 18333800
  15. [15]Badylak SF Taylor D Uygun K Whole-organ tissue engineering: decellularization and recellularization of three-dimensional matrix scaffolds. Annu Rev Biomed Eng 2011 13 27 53 21417722 PMC10887492
  16. [16]Song JJ Ott HC Organ engineering based on decellularized matrix scaffolds. Trends Mol Med 2011 17 424 32 21514224
  17. [17]Ott HC Matthiesen TS Goh SK Black LD Kren SM Netoff TI Perfusiondecellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med 2008 14 213 21 18193059
  18. [18]Ott HC Clippinger B Conrad C Schuetz C Pomerantseva I Ikonomou L Regeneration and orthotopic transplantation of a bioartificial lung. Nat Med 2010 16 927 33 20628374
  19. [19]Song JJ Guyette JP Gilpin SE Gonzalez G Vacanti JP Ott HC Regeneration and experimental orthotopic transplantation of a bioengineered kidney. Nat Med 2013 19 646 51 23584091 PMC3650107
  20. [21]Crapo PM Gilbert TW Badylak SF An overview of tissue and whole organ decellularization processes. Biomaterials 2011 32 3233 43 21296410 PMC3084613
  21. [22]Fiegel HC Kneser U Kluth D Metzger R Till H Rolle U Development of hepatic tissue engineering. Pediatr Surg Int 2009 25 667 73 19488762
  22. [23]Uygun BE Soto-Gutierrez A Yagi H Izamis ML Guzzardi MA Shulman C Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix. Nat Med 2010 16 814 20 20543851 PMC2930603
  23. [25]Kajbafzadeh AM Javan-Farazmand N Monajemzadeh M Baghayee A Determining the optimal decellularization and sterilization protocol for preparing a tissue scaffold of a human-sized liver tissue. Tissue Eng Part C Methods 2013 19 642 51 23270591
  24. [26]Lang R Stern MM Smith L Liu Y Bharadwaj S Liu G Three-dimensional culture of hepatocytes on porcine liver tissue-derived extracellular matrix. Biomaterials 2011 32 7042 52 21723601
  25. [27]Olausson M Patil PB Kuna VK Chougule P Hernandez N Methe K Transplantation of an allogeneic vein bioengineered with autologous stem cells: a proof-of-concept study. Lancet 2012 380 230 7 22704550
  26. [29]Wang Y Cui CB Yamauchi M Miguez P Roach M Malavarca R Lineage restriction of human hepatic stem cells to mature fates is made efficient by tissue-specific biomatrix scaffolds. Hepatology 2011 53 293 305 21254177
  27. [30]Keating A Mesenchymal stromal cells: new directions. Cell Stem Cell 2012 10 709 16 22704511
  28. [31]Ji R Zhang N You N Li Q Liu W Jiang N The differentiation of MSCs into functional hepatocyte-like cells in a liver biomatrix scaffold and their transplantation into liver-fibrotic mice. Biomaterials 2012 33 8995 9008 22985996
  29. [32]Kinoshita T Miyajima A Cytokine regulation of liver development. Biochim Biophys Acta 2002 1592 303 12 12421674
  30. [33]Duncan SA Mechanisms controlling early development of the liver. Mech Dev 2003 120 19 33 12490293
  31. [34]Oertel M Menthena A Dabeva MD Shafritz DA Cell competition leads to a high level of normal liver reconstitution by transplanted fetal liver stem/ progenitor cells. Gastroenterology 2006 130 507 20 16472603
  32. [35]Yovchev MI Grozdanov PN Zhou H Racherla H Guha C Dabeva MD Identification of adult hepatic progenitor cells capable of repopulating injured rat liver. Hepatology 2008 47 636 47 18023068
  33. [36]Katchman H Tal O Eventov-Friedman S Shezen E Aronovich A Tchorsh D Embryonic porcine liver as a source for transplantation: advantage of intact liver implants over isolated hepatoblasts in overcoming homeostatic inhibition by the quiescent host liver. Stem Cells 2008 26 1347 55 18339772

Cited by

Sorted by citations

Authors
Jiang, W.-C., Cheng, Y.-H., Yen, M.-H., Chang, Y., Yang, V. W., & Lee, O. K.
Affiliations
  • National Yang Ming University (TW)
  • Stony Brook School (US)
  • Taipei Veterans General Hospital (TW)
Corresponding author
Lee, Oscar K.
Venue
Biomaterials
Publisher
Elsevier BV
Published
2014-04
Volume
35
Issue
11
Pages
3607-3617
ISSN
0142-9612 (ISSN-L)
OpenAlex
W2067425028
Cited by
117
References
3
Citations by year
2026: 3 · 2025: 4 · 2024: 4 · 2023: 7 · 2022: 5 · 2021: 17 · 2020: 10 · 2019: 11 · 2018: 11 · 2017: 12 · 2016: 12 · 2015: 16 · 2014: 4
FWCI
14.55
Type
journal article
Language
en
Open access
Locations
  • Biomaterials (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Taiwan National Science Council I-RiCE Program (NSC101-2911-I-009-101)
  • Taipei Veterans General Hospital (VGH102E1-007, VGH102C-001)
  • National Science Council, Taiwan (NSC102-2120-M-010-002, NSC100-2314-B-010-030-MY3, NSC102-2321-B-010-008)
  • Ministry of Economic Affairs, Taiwan (102-EC-17-A-17-S1-203)
  • Ministry of Education
Topics
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
  • Health Sciences › Medicine › Genetics › Mesenchymal stem cell research
Keywords
mesenchymal stem cells, hepatic differentiation, liver transplantation, liver failure, 3D scaffolds, biomimetic scaffolds
MeSH terms
Animals, Cell Differentiation, Cold Temperature, Gene Expression Regulation, Liver, Mice, Inbred BALB C, Biomarkers, Liver Transplantation, Mice, SCID, Tissue Engineering, Mice, Tissue Scaffolds, Mesenchymal Stem Cells, Real-Time Polymerase Chain Reaction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review